I've made an essential 10 stock portfolio - what do you think. Would you add/remove any?
u/diggels ·
Reddit — r/ValueInvesting
· April 23, 2026 at 00:33
· ⬆ 15 pts
· 💬 51 comments
| View on Reddit ↗
AI Summary
Summary
Author presents a 10-stock portfolio aiming for stable high growth with minimal diversification.
Thesis: Concentrated bet on AI and tech leaders at "good prices and trends," anchored by Berkshire, healthcare, and defense.
Quality assessment: Speculation / noise. No fundamental analysis provided; based on trends and roles.
Score15
Comments51
Upvote %67%
▶ Full Post Text
I'm looking to build a stable , high growth portfolio. But not looking to diversify too much. These are mostly at good prices and trends.
What do you think, what would you add or remove, if any?
| # | Ticker | Name | Role | Target |
|---|--------|------|------|--------|
| 1 | NVDA | Nvidia | AI Growth #1 | 14% |
| 2 | ASML | ASML | AI Growth #2 | 13% |
| 3 | MSFT | Microsoft | Cloud / AI | 12% |
| 4 | BRK.B | Berkshire B | Macro Anchor | 12% |
| 5 | GOOGL | Alphabet | AI + Ads | 11% |
| 6 | AMZN | Amazon | AWS + AI | 10% |
| 7 | AVGO | Broadcom | AI Silicon | 8% |
| 8 | TSM | Taiwan Semi | AI Fab | 8% |
| 9 | ABBV | AbbVie | Healthcare | 7% |
| 10 | RTX | RTX Corp | Defence | 5-8% |
Listed as "AI Growth #1" with 14% target allocation. Positioned as primary beneficiary of AI infrastructure spending. Core holding for high growth in a concentrated portfolio. AI hype cycle correction, valuation extremes, competition.
"Macro Anchor" with 12% allocation. Provides diversification and downside protection in a tech-heavy portfolio. Intended as a stabilizing force and value component. Buffett succession, limited growth vs. tech peers, concentrated equity portfolio.
"AI Growth #2" with 13% allocation. Monopoly on EUV lithography critical for advanced AI chips. Essential infrastructure play for AI semiconductor manufacturing. Geopolitical risks (Netherlands/China), cyclical semiconductor capex.
"Cloud / AI" role with 12% allocation. Diversified AI exposure through Azure, OpenAI partnership, and enterprise software. Blue-chip AI and cloud anchor with stable growth profile. Slowing cloud growth, regulatory scrutiny, execution risk in AI.
"Healthcare" allocation at 7%. Non-tech exposure for stability and dividend income. Defensive sector allocation to reduce portfolio volatility. Patent cliffs, drug pricing pressures, pipeline setbacks.
This Reddit post, published April 23, 2026,
features u/diggels
discussing NVDA, BRK.B, ASML, MSFT, ABBV.
5 trade ideas extracted by AI with direction and confidence scoring.